Cargando…
Excessive esophageal toxicity in patients with locally advanced non-small cell lung cancer treated with concurrent hypofractionated chemoradiotherapy and 3-weekly platinum doublet chemotherapy
INTRODUCTION: Concurrent chemoradiation followed by immunotherapy is the standard of care for patients with stage III non-small cell lung cancer (NSCLC). Prior to the introduction of adjuvant immunotherapy, we treated patients with stage III NSCLC with concurrent platinum doublet chemotherapy and 66...
Autores principales: | van der Voort van Zyp, Noëlle, Hashimzadah, Masoma, Kouwenhoven, Erik, Liskamp, Carmen, Gadellaa-van Hooijdonk, Christa, Pouw, Ellen, Belderbos, Jose, Maas, Klaartje, van de Vaart, Paul, Mast, Mirjam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283504/ https://www.ncbi.nlm.nih.gov/pubmed/35847053 http://dx.doi.org/10.1016/j.ctro.2022.07.002 |
Ejemplares similares
-
Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer
por: Cho, Ick Joon, et al.
Publicado: (2023) -
Treatment of Stage IV Non–Small Cell Lung Cancer with Pembrolizumab in Combination with Platinum-Based Doublet Chemotherapy in Vietnam
por: Nguyen, Khanh Toan, et al.
Publicado: (2023) -
Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear accelerator
por: den Hartogh, Mariska D., et al.
Publicado: (2019) -
Assessing Recent Time-Dependent Double-Hybrid Density
Functionals on Doublet–Doublet Excitations
por: Van Dijk, Joshua, et al.
Publicado: (2022) -
Two years’ experience with inspiration breath-hold in liver SBRT
por: Mast, M., et al.
Publicado: (2018)